Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Avidity Biosciences (RNA) Asset Utilization Ratio (2020 - 2025)

Avidity Biosciences (RNA) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.01 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Asset Utilization Ratio fell 17.71% year-over-year to 0.01, compared with a TTM value of 0.01 through Jun 2025, down 17.71%, and an annual FY2025 reading of 0.01, up 7.14% over the prior year.
  • Asset Utilization Ratio was 0.01 for Q2 2025 at Avidity Biosciences, up from 0.01 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.03 in Q2 2021 and bottomed at 0.01 in Q1 2025.
  • Average Asset Utilization Ratio over 5 years is 0.02, with a median of 0.02 recorded in 2023.
  • The sharpest move saw Asset Utilization Ratio soared 54.6% in 2021, then tumbled 57.08% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.02 in 2021, then fell by 21.06% to 0.02 in 2022, then fell by 7.77% to 0.02 in 2023, then tumbled by 42.05% to 0.01 in 2024, then dropped by 17.71% to 0.01 in 2025.
  • Business Quant data shows Asset Utilization Ratio for RNA at 0.01 in Q2 2025, 0.01 in Q1 2025, and 0.01 in Q2 2024.